Lab leader: Shaoqin “Sarah” Gong
Prof. Gong’s research group focuses on the design, synthesis/fabrication, and characterization of novel biomaterials and nanomaterials for various medical and biomedical applications. Many of our ongoing projects are multidisciplinary, bridging engineering with chemistry, materials science, and life sciences. In particular, we have engineered a series of multifunctional drug/agent nanocarriers (e.g., unimolecular nanoparticles, polymer micelles and vesicles, polymer nanocages, and functionalized inorganic nanoparticles) for the (co)delivery of therapeutic and diagnostic agents that can be used to treat and diagnose various types of diseases (e.g., cancers, vascular diseases, brain diseases, and eye diseases). Our current efforts focus on engineering non-viral nanodelivery systems for CRISPR genome editing machinery as well as nanomedicines for cancer immunotherapy and various other types of diseases.